{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-282412","form_type":"8-K/A","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2021-09-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.055276+00:00","generated_at":"2026-06-29T01:30:42.435860+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"Aadi Bioscience files historical audited financials of acquired private company showing $32.6M deficit","bullets":["Old Aadi reported net loss of $3.5M for 2020, revenue of $14.6M (primarily $14M license revenue).","Accumulated deficit of $32.6M as of Dec 31, 2020; cash and equivalents of $4.5M.","Auditor's report includes substantial doubt about going concern due to recurring losses and negative cash flows.","As of Dec 31, 2020, the company had $14.3M payable to related party Celgene and $9M convertible promissory notes.","Merger with Aadi Bioscience, Inc. closed Aug 26, 2021; these are the acquired entity's historical financials."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-282412","json":"https://secwatch.observer/filing/0001193125-21-282412.json","markdown":"https://secwatch.observer/filing/0001193125-21-282412.md","text":"https://secwatch.observer/filing/0001193125-21-282412.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312521282412/0001193125-21-282412-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312521282412/d207285d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T01:30:42.435860+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}